Background Imaging-based patient selection for neurothrombectomy is reliant on the identification of irreversibly damaged brain tissue (core) and salvageable tissue (penumbra). The DAWN trial used the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback